Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Clinical Trial Investigators

InstitutionResearch output, impact & collaborations

Clinical Trial Investigators is a research organisation in Tustin, US. OpenAlex records 149 works and 326,665 citations for it. 2,691 researchers list it as their most recent affiliation.

149
Works
326,665
Citations
2,691
Researchers
57.8
Avg h-index

How has Clinical Trial Investigators's publication output changed over time?

ScholarIQpublication output · 1994–2021

Output grew0% over the shown period — from 1 works in 1994 to 1 in 2021.

1
1
1
2
2
1
1
1
1
1
1994199920012005200820102012201720192021

Who are the most-cited researchers behind Clinical Trial Investigators?

ScholarIQtop researchers by citations
1
Bernhard Ludvik · Diabetes Treatment and Management
280 works13,366 citations
2
Vincent Esnault · Renal Diseases and Glomerulopathies
198 works7,183 citations

What are the most-cited papers on Clinical Trial Investigators?

ScholarIQmost cited works
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
John J. Nolan, Bernhard Ludvik, P. Beerdsen, M. Joyce, Jerrold M. Olefsky
New England Journal of Medicine. 1994935 CitationsOPEN ACCESS
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)
Judy Savige, David Gillis, Elizabeth M. Benson, D.J.G. Davies, Vincent Esnault, Ronald J. Falk, E. Chris Hagen, David Jayne, J. Charles Jennette, Bill Paspaliaris, Wendy Pollock, Charles D. Pusey, Caroline O. S. Savage, Roger Silvestrini, Fokko van der Woude, Jörgen Wieslander, Allan Wiik
S15871148. 1999883 CitationsOPEN ACCESS
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux, Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortíz, John P H Wilding, Trine Vang Skjøth, Linda Shapiro Manning, Xavier Pi-Sunyer, A. Hamann, Alain Barakat, Matthias Blüher, Thomas Linn, Andrea Mölle, Alexander Segner, Petra Stübler, Regina Tosch-Sisting, Furio Pacini, Ferruccio Santini, Giulio Marchesini, Carlo Maria Rotella, Cecilia Invitti, Roberto Vettor, Silvio Buscemi, Pedro Mezquita Raya, Felipe Casanueva Freijoo, Ramón Gomis de Barbará, Raffaele Carraro, Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Vernon Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudesh Kumar, Carel Wynard Le Roux, Carel Wynard Le Roux, Michael E.J. Lean, Barbara McGowan, Tariq Rehman, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, Ambika Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos
The Lancet. 2017856 Citations
A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test
Andrea Mari, Giovanni Pacini, Elaine Murphy, Bernhard Ludvik, John J. Nolan
Diabetes Care. 2001805 CitationsOPEN ACCESS
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Bernhard Ludvik, Francesco Giorgino, Esteban Jódar, Juan P. Frías, Laura Fernández Landó, Katelyn Brown, Ross Bray, Ángel Rodríguez
The Lancet. 2021621 Citations

How much of the research on Clinical Trial Investigators is open access?

ScholarIQopen access share
42%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
0%
Bronze
25%
Closed
58%

Related on ScholarIQ

Radioactive element chemistry and processing
Top Topic
Inflammatory Bowel Disease
Top Topic
Respiratory Support and Mechanisms
Top Topic
Bariatric Surgery and Outcomes
Top Topic
Acute Ischemic Stroke Management
Top Topic
Venous Thromboembolism Diagnosis and Management
Top Topic
470M+ articles · free account